UK Markets open in 7 hrs 35 mins

Tiziana Life Sciences PLC (TIZAF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
1.00000.0000 (0.00%)
At close: 11:53AM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5N/A
Enterprise value 3N/A
Trailing P/E N/A
Forward P/E 1N/A
PEG ratio (5-yr expected) 1N/A
Price/sales (ttm)N/A
Price/book (mrq)N/A
Enterprise value/revenue 3N/A
Enterprise value/EBITDA 7N/A

Trading information

Stock price history

Beta (5Y monthly) -0.08
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 33.0000
52-week low 30.8200
50-day moving average 31.2530
200-day moving average 31.2000

Share statistics

Avg vol (3-month) 3446
Avg vol (10-day) 3N/A
Shares outstanding 5194.61M
Implied shares outstanding 6N/A
Float 890.47M
% held by insiders 149.41%
% held by institutions 15.22%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Dec 2020

Profitability

Profit margin 0.00%
Operating margin (ttm)0.00%

Management effectiveness

Return on assets (ttm)-52.05%
Return on equity (ttm)-91.89%

Income statement

Revenue (ttm)N/A
Revenue per share (ttm)N/A
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA -30.41M
Net income avi to common (ttm)-26.13M
Diluted EPS (ttm)N/A
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)65.82M
Total cash per share (mrq)0.34
Total debt (mrq)555k
Total debt/equity (mrq)0.89
Current ratio (mrq)8.79
Book value per share (mrq)N/A

Cash flow statement

Operating cash flow (ttm)-11.34M
Levered free cash flow (ttm)-2.58M